A detailed history of Israel Englander (Millennium Management LLC) transactions in Geron Corp stock. As of the latest transaction made, Millennium Management LLC holds 4,120,205 shares of GERN stock, worth $14.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,120,205
Previous 7,650,414 46.14%
Holding current value
$14.4 Million
Previous $32.4 Million 42.33%
% of portfolio
0.01%
Previous 0.02%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.17 - $4.99 $14.7 Million - $17.6 Million
-3,530,209 Reduced 46.14%
4,120,205 $18.7 Million
Q2 2024

Aug 14, 2024

BUY
$3.1 - $5.09 $1.08 Million - $1.77 Million
348,118 Added 4.77%
7,650,414 $32.4 Million
Q1 2024

May 15, 2024

SELL
$1.75 - $3.44 $13 Million - $25.6 Million
-7,428,690 Reduced 50.43%
7,302,296 $24.1 Million
Q4 2023

Feb 14, 2024

BUY
$1.74 - $2.31 $4.39 Million - $5.83 Million
2,522,697 Added 20.66%
14,730,986 $31.1 Million
Q2 2023

Aug 14, 2023

BUY
$1.97 - $3.69 $13.6 Million - $25.4 Million
6,882,395 Added 129.23%
12,208,289 $39.2 Million
Q1 2023

May 15, 2023

BUY
$2.14 - $3.4 $3.21 Million - $5.1 Million
1,500,148 Added 39.21%
5,325,894 $11.6 Million
Q4 2022

Feb 14, 2023

BUY
$2.03 - $2.42 $5.13 Million - $6.12 Million
2,526,953 Added 194.56%
3,825,746 $9.26 Million
Q3 2022

Nov 14, 2022

SELL
$1.67 - $2.94 $1.15 Million - $2.02 Million
-686,182 Reduced 34.57%
1,298,793 $3.04 Million
Q2 2022

Aug 15, 2022

SELL
$1.19 - $1.65 $215,037 - $298,161
-180,704 Reduced 8.34%
1,984,975 $3.08 Million
Q1 2022

May 16, 2022

BUY
$0.99 - $1.6 $1.47 Million - $2.37 Million
1,483,844 Added 217.63%
2,165,679 $2.95 Million
Q4 2021

Feb 14, 2022

SELL
$1.22 - $1.72 $913,631 - $1.29 Million
-748,878 Reduced 52.34%
681,835 $832,000
Q3 2021

Nov 15, 2021

BUY
$1.2 - $1.5 $637,862 - $797,328
531,552 Added 59.12%
1,430,713 $1.96 Million
Q2 2021

Aug 16, 2021

SELL
$1.25 - $1.83 $414,373 - $606,643
-331,499 Reduced 26.94%
899,161 $1.27 Million
Q1 2021

May 17, 2021

SELL
$1.52 - $2.1 $2.87 Million - $3.96 Million
-1,886,082 Reduced 60.51%
1,230,660 $1.94 Million
Q4 2020

Feb 16, 2021

BUY
$1.55 - $2.05 $3.67 Million - $4.85 Million
2,366,468 Added 315.41%
3,116,742 $4.96 Million
Q3 2020

Nov 16, 2020

BUY
$1.59 - $2.19 $1.17 Million - $1.61 Million
734,246 Added 4581.02%
750,274 $1.31 Million
Q2 2020

Aug 14, 2020

SELL
$1.05 - $2.18 $14,177 - $29,434
-13,502 Reduced 45.72%
16,028 $35,000
Q1 2020

May 14, 2020

BUY
$0.89 - $1.49 $26,281 - $43,999
29,530 New
29,530 $35,000
Q2 2019

Aug 14, 2019

SELL
$1.37 - $2.02 $611,124 - $901,073
-446,076 Closed
0 $0
Q1 2019

May 14, 2019

SELL
$1.01 - $1.83 $293,133 - $531,122
-290,231 Reduced 39.42%
446,076 $740,000
Q4 2018

Feb 14, 2019

BUY
$0.98 - $1.85 $709,445 - $1.34 Million
723,924 Added 5846.11%
736,307 $736,000
Q2 2018

Aug 14, 2018

SELL
$3.29 - $4.82 $294,181 - $430,989
-89,417 Reduced 87.84%
12,383 $42,000
Q4 2017

Feb 14, 2018

BUY
$1.8 - $2.32 $156,031 - $201,106
86,684 Added 573.46%
101,800 $183,000
Q3 2017

Nov 14, 2017

BUY
$1.99 - $2.65 $30,080 - $40,057
15,116
15,116 $33,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.32B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.